ResMed posts ‘lower than anticipated’ results
SAN DIEGO – ResMed’s fourth quarter revenues were $415.2 million, flat when compared to the same period last year, the company announced yesterday.
Net income was $87.7 million for the three months ended June 30, a 20% increase.
“Our fourth quarter results were lower than anticipated, the result of softer sales in the Americas, partially offset by good growth in international markets,” stated Mick Farrell, CEO, in a press release.
Fourth quarter revenues in the Americas were $214.9 million, down 7% compared to the same period last year.
For fiscal year 2014, revenues were $1.56 billion, a 3% increase over fiscal year 2013. Net income was $345.3 million, a 12% increase.